Elson B C, Helvie M A, Frank T S, Wilson T E, Adler D D
Department of Radiology, University of Michigan Medical Center, Ann Arbor 48109.
AJR Am J Roentgenol. 1993 Dec;161(6):1173-6. doi: 10.2214/ajr.161.6.8249721.
Tubular carcinoma of the breast is a distinct, well-differentiated histologic subtype of infiltrative adenocarcinoma. The purpose of this study was to determine the typical mode of presentation, mammographic appearance, and frequency of metastases to the axillary lymph nodes.
We retrospectively analyzed the clinical records, mammograms, and histologic slides of 20 cases of proved tubular carcinoma of the breast in 20 women. These patients were identified by computerized search of our pathology data base from 1984 to 1993. Histologic findings were reviewed in all cases and correlated with the mammographic findings.
Thirteen (65%) of the 20 women had impalpable tubular cancers discovered on screening mammograms. Seven patients (35%) had mammography because of a palpable tumor. Abnormalities were seen on mammograms in 16 patients (80%). These consisted of a mass alone in 13 (65%), a mass with microcalcifications in two (10%), and calcifications associated with architectural distortion and asymmetric density in one (5%). Most masses (11/15, 73%) were irregular or spherical and had spiculated margins. The size of the masses ranged from 3 to 19 mm (median, 8 mm). Metastatic carcinoma was found in the axillary lymph nodes of four (29%) of 14 patients who had axillary lymph node dissections, three of whom had a primary tumor 1 cm or less in diameter.
Tubular cancers were most frequently detected as impalpable abnormalities seen on mammograms, emphasizing the importance of screening mammography. However, tubular carcinomas did not have a unique appearance on mammograms that would allow differentiation from other carcinomas. Lymph node metastases were more common than has been previously reported for this type of tumor, indicating that axillary lymph node dissections should continue to be performed.
乳腺管状癌是浸润性腺癌中一种独特的、高分化的组织学亚型。本研究的目的是确定其典型的临床表现方式、乳腺钼靶表现以及腋窝淋巴结转移频率。
我们回顾性分析了20例经病理证实为乳腺管状癌的20名女性患者的临床记录、乳腺钼靶片和组织学切片。这些患者是通过计算机检索我们1984年至1993年的病理数据库确定的。对所有病例的组织学结果进行了复查,并与乳腺钼靶检查结果进行了关联。
20名女性中有13名(65%)在乳腺钼靶筛查中发现了触诊不到的管状癌。7名患者(35%)因可触及肿块而进行了乳腺钼靶检查。16名患者(80%)的乳腺钼靶片上出现了异常。其中13名(65%)仅表现为肿块,2名(10%)为伴有微钙化的肿块,1名(5%)为伴有结构扭曲和不对称密度的钙化。大多数肿块(11/15,73%)不规则或呈球形,边缘有毛刺。肿块大小范围为3至19毫米(中位数为8毫米)。在14名接受腋窝淋巴结清扫的患者中,4名(29%)发现腋窝淋巴结有转移癌,其中3名患者的原发肿瘤直径为1厘米或更小。
管状癌最常作为乳腺钼靶片上触诊不到的异常被发现,强调了乳腺钼靶筛查的重要性。然而,管状癌在乳腺钼靶片上没有独特的表现,无法与其他癌相鉴别。淋巴结转移比此前报道的这类肿瘤更为常见,表明仍应继续进行腋窝淋巴结清扫。